Shares of Eurofins Scient (OTCMKTS:ERFSF – Get Free Report) saw strong trading volume on Tuesday. Approximately 36,380 shares traded hands during mid-day trading, an increase of 849% from the average daily volume of 3,835 shares. The stock last traded at $95.7901 and had previously closed at $96.1580.
Wall Street Analysts Forecast Growth
Separately, Sanford C. Bernstein lowered Eurofins Scient from an “outperform” rating to a “hold” rating in a report on Tuesday, September 29th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Eurofins Scient has an average rating of “Hold”.
Read Our Latest Research Report on ERFSF
Eurofins Scient Trading Up 0.1%
The business’s 50 day simple moving average is $87.70 and its two-hundred day simple moving average is $79.53. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.07 and a current ratio of 1.13.
Eurofins Scient Company Profile
Eurofins Scientific SE is a Luxembourg-based international laboratory and testing services company. It provides analytical, inspection and certification services for the pharmaceutical, food, environmental, agricultural, consumer products and healthcare industries.
The company’s services include laboratory testing, product safety and quality analysis, environmental monitoring, pharmaceutical development and validation, genomic testing, clinical diagnostics, and agroscience services. Eurofins also supports companies and public-sector organizations with research, regulatory compliance and quality-control programs.
Founded in 1987 by Gilles Martin, Eurofins has expanded from its original focus on food testing into a broad network of laboratories and specialized testing businesses serving customers in Europe, North America, Asia-Pacific and other international markets.
Featured Articles
- Five stocks we like better than Eurofins Scient
- Republic Services Has the Momentum, But Waste Management Has Another Advantage
- Alphabet’s Golden Dome Talks Could Open a New Market, But How Much Is at Stake?
- Tempus AI Surges on Earnings Beat, But Can the Rally Last?
- MicroVision Pivots: Mapping New Ground Beyond Auto
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
